Fillyaboots Forums: Alizyme worth a look

Active Topics

Memberlist

Help

General Trading
Fillyaboots Forums : General Trading

Topic: Alizyme worth a look

Author

Message

<< Prev Topic | Next Topic >>

Hipster
Platinum Contributor

Joined: 15-Oct-02
Location: United Kingdom
Posts: 830

Posted: 16-Apr-07 at 23:44 \| IP Logged

Ive bought into Alizyme a number of times over the last month and showing a healthy profit.( Lots more up side IMHO)I Like the chart and volume etc etc Check out the last few RNS reports plus recent coverage by broadsheet press No advice intended etc

Krabthearab
Regular Contributor

Joined: 20-Dec-07
Location: United Kingdom
Posts: 65

Posted: 02-Jan-08 at 20:25 \| IP Logged

Hipster,

This company seems to have a stable of promising drugs, but delivers no deals, the price has been droping like a stone then surges today.

Any idea's why? Has it bottomed?

Krabthearab
Regular Contributor

Joined: 20-Dec-07
Location: United Kingdom
Posts: 65

Posted: 10-Jan-08 at 09:37 \| IP Logged

Feeling almost as unloved as this share, no one on here ever replies to my posts......boo hoo.

This share goes up to 65ish, then blasts back down to 50. Everything i read says product pipeline and huge potential, but limited partnering deals so far.

Other B.B's ridicule management, just wonder if anyone here got any views on it?

If you wish to post a reply to this topic you must first login
If you are not already registered you must first register

Printable version

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot delete your posts in this forum
You cannot edit your posts in this forum
You cannot create polls in this forum
You cannot vote in polls in this forum

This page was generated in 0.1563 seconds.

DISCLAIMER: The posts on this Bulletin Board are the views of the respective authors and do NOT represent the views of FillyaBoots! or its affiliates. This facility is intended for your interactive assistance and enjoyment only without any warranty or guarantee whatsoever. Specifically, it is NOT investment advice and must not be construed as such.